Part of the Physical Sciences and Mathematics Commons
2020
Efficacy of Delayed-Release Dimethyl Fumarate vs Glatiramer Acetate on a Novel Composite Outcome Measure of Inflammatory Disease Activity: Post-Hoc Analysis of the CONFIRM Study, M. Kremenchutzky, R. J. Fox, J. T. Phillips, Mariko Kita, Karl E. Peace, J. B. Lewin, A. Zhang, M Okwuokenye, M Edwards, J Marantz
Karl E. Peace
2018
Efficacy of Delayed-Release Dimethyl Fumarate vs Glatiramer Acetate on a Novel Composite Outcome Measure of Inflammatory Disease Activity: Post-Hoc Analysis of the CONFIRM Study, Marcelo Kremenchutzky, Robert J. Fox, J. Theodore Phillips, Mariko Kita, Karl E. Peace, James B. Lewin, Annie Zhang, Macaulay Okwuokenye, Michael R. Edwards, Jing L. Marantz
Karl E. Peace
2015
Efficacy of Delayed-Release Dimethyl Fumarate vs Glatiramer Acetate on a Novel Composite Outcome Measure of Inflammatory Disease Activity: Post-Hoc Analysis of the CONFIRM Study, Marcelo Kremenchutzky, Robert J. Fox, J. Theodore Phillips, Mariko Kita, Karl E. Peace, James B. Lewin, Annie Zhang, Macaulay Okwuokenye, Michael R. Edwards, Jing L. Marantz
Biostatistics Faculty Publications
Efficacy of Delayed-Release Dimethyl Fumarate vs Glatiramer Acetate on a Novel Composite Outcome Measure of Inflammatory Disease Activity: Post-Hoc Analysis of the CONFIRM Study, M. Kremenchutzky, R. J. Fox, J. T. Phillips, Mariko Kita, Karl E. Peace, J. B. Lewin, A. Zhang, M Okwuokenye, M Edwards, J Marantz
Biostatistics Faculty Presentations
Efficacy of Delayed-Release Dimethyl Fumarate vs Glatiramer Acetate on a Novel Composite Outcome Measure of Inflammatory Disease Activity: Post-Hoc Analysis of the CONFIRM Study, Marcelo Kremenchutzky, Robert J. Fox, J. Theodore Phillips, Mariko Kita, Karl E. Peace, James B. Lewin, Annie Zhang, Macaulay Okwuokenye, Michael R. Edwards, Jing L. Marantz
Karl E. Peace
